New PET scan for detecting certain diseases
Part of Cancer, Heart & circulation, Lungs & breathing clinical trials.
This trial uses a special PET scan tracer to see if it can help find and monitor diseases linked to a protein called FAP. It is for both cancer patients needing a biopsy and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- For cancer patients: you can have surgery or a biopsy to get a diagnosis.
- For healthy volunteers: you have no ongoing health conditions like high blood pressure, diabetes, heart disease, kidney disease, or cancer.
- You are not pregnant or breastfeeding.
- You are not allergic to any ingredients in the study drug.
- Your kidney and liver function are good (blood creatinine levels below 159 μmol/L).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.
This trial tests a new type of PET/CT scan that uses a special tracer (called ⁶⁸Ga-FXX489) to help find and diagnose cancers. It is for people who are strongly suspected to have cancer and want to see if this new imaging method can help their doctors learn more about their disease.
This trial uses a special PET scan to look at heart tissue in people with nonischemic cardiomyopathy. The scan may help doctors better understand the condition and guide treatment.
This trial uses a special PET scan to look at diseases like cancer. It aims to see if this new imaging method can help doctors find or monitor disease better. This could be helpful for people with confirmed or suspected cancer or other conditions.
This study tests how useful a special PET/CT scan (called 68Ga-FAPI) is for people who may have or have been diagnosed with cancer. The scan may help doctors see cancer activity more clearly.
This trial tests a new imaging agent called 68Ga-NI-FAPI to see how well it works in a PET scan for people with different types of solid tumors. The goal is to help doctors better see and understand tumors.
Hear when a new Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.